Scientists have created a bioengineered 3-D model that mimics the biology of two rare diseases. The researchers used the 'tissue chip' model to show how a drug could potentially treat the diseases, providing data for a drug company's FDA submission for authorization for clinical testing. This is one of the first examples of using primarily tissue chip data for an FDA application to test the efficacy of a candidate drug for rare diseases.
